View more job listings or post a job
Pliant Therapeutics This highly visible leadership role thrives through fierce collaboration with multidisciplinary teams, embracing broad experience in modern DMPK science to optimize and advance both small and large molecule candidates.  
Vir Biotechnology Senior Scientist I, Computational Chemistry
Vir Biotechnology Scientist II, Assay Automation & Compound Screening
FibroGen Senior Director Clinical Pharmacology
University of California, Davis TOXICOLOGY GROUP LEADER (LABORATORY RESCHEARCH SUPERVISOR 2)                    
Xencor Scientist, Immuno-Oncology
Xencor Research Associate 3, Immuno-Oncology
Genentech Senior Scientist, Small Molecule Analytical Chemistry
Roivant Sciences Director, Translational Sciences and Immunology
Horizon Therapeutics Senior Clinical Pharmacologist
Post a job


[Free Online Workshop] New Product Launch: What Does it Take to Bring a New Product to Market?

Speakers: Angie Lewis-White, Myovant Sciences; Eileen Ring, Alladapt Immunotherapeutics Inc.; Renard Jackson, Frontida BioPharm, Inc.; Lewis Stuart, CymaBay Therapeutics, Inc.; Kurt Mayrand, ChemoCentrys; John Farris, Graphite Bio
Organizers: Minli Xie, Erasca Inc.; Angie Lewis-White, Myovant Sciences
Date: 2023-02-08- 02/09/2023
Time: 8:30-12:30 Pacific Time
Registration fee: Free
Location: Online via zoom
Major Sponsor:
Vendor show vendors registered to date:
Registration deadline:2023-02-04  (it will close sooner if the seating cap is reached)

About the Topic

After years of hard work in research and development of a new drug, what does it take for a small entrepreneur company to successfully launch a new product in this highly competitive and highly regulated environment.  Drug launch requires a cross-functional planning, coordination and implementation, and this workshop will describe the key areas and activities go into preparation and execute a launch including some case studies.  Often, decisions made early during development would impact launch preparations. The goal of this workshop is to provide some fundamentals on:

1) an overview to key elements for a new product launch including considerations during early research & development
2) creating a commercial plan through market research, brand establishment and building a sales force
3) important role of market access and process of establishing market access
4) meeting the compliance requirements in both quality and regulatory aspects 
5) understanding on importance of a robust commercial supply chain in today’s world
6) what is involved with serialization and third-party logistics

Note: This is an online meeting, The Zoom link will be sent to the registrants 1+ days before the event.

About the Speakers

The speakers are experienced leaders in the Pharma/Biotech industry who have taken multiple products to market successfully.  They will share their experiences and bring these fundamentals to life through examples.


Session 1 (Feb. 8, 2023)





8:30-8:35 am

11:30-11:35 am

Welcome Remarks

Minli Xie, Erasca Inc.

8:35-9:30 am

11:45am-12:30 pm

Commercial Supply Chain

Angie Lewis-White, MyovantSciences Inc.

9:30-10:15 am

12:30-1:15 pm

Packaging & Serialization

Eileen Ring, AlladaptImmunotherapeutics Inc.

10:15-10:30 am

1:15-1:30 pm



10:30-11:15 am

1:30-2:15 pm

3PL & Inventory Management

Angie Lewis-White, MyovantSciences Inc.

11:15am -12:00 pm

2:15-3:00 pm

Supplier Contributions/Perspectives

Renard Jackson, Adare Pharma Solutions

12:00-12:30 pm

3:00-3:30 pm

Session 1 Q&A



Session 2 (Feb. 9, 2023)





8:30-8:35 am


Welcome Remarks

Minli Xie, Erasca Inc.

8:35-9:30 am


Marketing Research & Commercialization Strategy

Lewis Stuart, CymaBayTherapeutics, Inc.

9:30-10:30 am


Market Access (Pricing and Reimbursement)

Kurt Mayrand, ChemoCentryx Inc. (Amgen)

10:30-10:45 am




10:45-11:45 am


Quality and Regulatory Considerations

John Farris, Graphite Bio Inc.

11:45am-12:30 pm

2:45-3:30 pm

Session 2 Q&A

Panel Discussion


2023-04-03, [Free Online Symposium] Pediatric Drug Development: Regulatory and Clinical Considerations and Clinical Pharmacology Approaches
2023-04-24, [In-Person] Preclinical Development & IND Filing for Small Molecules: Nuts, Bolts and Best Practices
2023-05-24, [In-Person] Preclinical Development and IND Filing for Antibody-Based Therapeutics: Nuts, Bolts and Best Practices
2023-05-26, [Free Online Workshop] Nonclinical Carcinogenicity Studies: Fundamentals, Case Studies and Regulatory Trends
2023-06-20, [Free Online Symposium] Highlights of 2022 FDA Approvals
©Pharmaceutical & BioScience Society, International; Last Modified: 3/20/2023; Admin Logon
Ads (in random order)
Submit a Text Ad
($250 for 2 months)

BioTether Sciences CRO focused on bioanalysis and cell-based assays. Regulated analysis for immunogenicity and PK/PD. Gene and cell therapy product characterization.
Origin Bioanalytical Laboratory, Inc. Bioanalytical CRO specializing in LC-MS/MS method development, validation, non-GLP and GLP analysis to support PK/TK studies, with ocular expertise.
Hypha Discovery Synthesis, purification & NMR characterization of phase I and II drug metabolites & API impurities at mg-g scale with COAs.
Alturas Analytics, Inc. Expert GLP & non-GLP LC-MS/MS, GC-MS/MS bioanalytical & PK/TK analysis services of small & large molecules in any matrix. Discovery through phase IV.
Submit a Text Ad